Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
International Journal of Cardiology|June 1, 1991
Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable anginaJ S Gibbs, H M McAlpine, C Wright, et al.
The American Journal of Cardiology|November 15, 1995
Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study GroupY Bashir, P E Thomsen, J H Kingma, et al.
British Heart Journal|March 1, 1993
Early treatment with captopril after acute myocardial infarctionS G Ray, M Pye, K G Oldroyd, et al.
Cardiovascular Research|July 1, 1988
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusionM J Walker, M J Curtis, D J Hearse, et al.
Circulation|February 7, 2001
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyD J Freeman, J Norrie, N Sattar, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 23, 2002
Task Force on Sudden Cardiac Death, European Society of CardiologyS G Priori, E Aliot, C Blømstrom-Lundqvist, et al.
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at RiskP J Houx, J Shepherd, G-J Blauw, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
European Journal of Epidemiology|September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, J Danesh, S Erqou, et al.
Pageof 15